Celldex Therapeutics
CLDX
#4622
Rank
C$3.08 B
Marketcap
C$39.32
Share price
-1.93%
Change (1 day)
11.97%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2026 (TTM): C-$6.05

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is C-$6.24. In 2025 the company made an earnings per share (EPS) of C-$5.58 a decrease over its 2024 EPS that were of C-$3.51.

EPS history for Celldex Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$6.058.51%
2025C-$5.5858.78%
2024C-$3.51
2022C-$3.4345.73%
2021C-$2.35-23.36%
2020C-$3.07-41.05%
2019C-$5.21-76.95%
2018C-$22.59
2016C-$27.10-3.82%
2015C-$28.18-0.76%
2014C-$28.39
2012C-$21.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.02-116.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$24.92-499.54%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.13-166.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
C-$6.30 0.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
C-$5.75-7.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$2.90-146.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C-$7.23 15.86%๐Ÿ‡บ๐Ÿ‡ธ USA